Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty(Ⓡ)])

por Ando, Masaru, Satonaga, Yoshio, Takaki, Ryuichiro, Yabe, Michitoshi, Kan, Takamasa, Omote, Erika, Yamasaki, Toru, Komiya, Kosaku, Hiramatsu, Kazufumi
Publicado 2022

Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation

por Kodama, Hiroaki, Kenmotsu, Hirotsugu, Kawabata, Takanori, Notsu, Akifumi, Yabe, Michitoshi, Nishioka, Naoya, Miyawaki, Eriko, Miyawaki, Taichi, Mamesaya, Nobuaki, Kobayashi, Haruki, Omori, Shota, Wakuda, Kazushige, Ono, Akira, Naito, Tateaki, Murakami, Haruyasu, Takahashi, Toshiaki
Publicado 2021

Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer

por Nishimura, Ari, Ono, Akira, Wakuda, Kazushige, Kawabata, Takanori, Yabe, Michitoshi, Miyawaki, Taichi, Miyawaki, Eriko, Kodama, Hiroaki, Nishioka, Naoya, Mamesaya, Nobuaki, Kobayashi, Haruki, Omori, Shota, Kenmotsu, Hirotsugu, Naito, Tateaki, Murakami, Haruyasu, Harada, Hideyuki, Takahashi, Toshiaki
Publicado 2021

Impact of losing adipose tissue on outcomes from PD‐1/PD‐L1 inhibitor monotherapy in non‐small cell lung cancer

por Nishioka, Naoya, Naito, Tateaki, Miyawaki, Taichi, Yabe, Michitoshi, Doshita, Kosei, Kodama, Hiroaki, Miyawaki, Eriko, Iida, Yuko, Mamesaya, Nobuaki, Kobayashi, Haruki, Omori, Shota, Ko, Ryo, Wakuda, Kazushige, Ono, Akira, Kenmotsu, Hirotsugu, Murakami, Haruyasu, Takayama, Koichi, Takahashi, Toshiaki
Publicado 2022